Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Fukuyama
Institution:
Boehringer Ingelheim (Japan)
Observed institution:
Boehringer Ingelheim (Japan)
OpenAlex ID:
A5122838848
A phase I first in human, open-label, multicenter study of BI3706674, KRAS multi-inhibitor, monotherapy in patients with advanced solid tumors bearing KRAS WT amp.
2026
·
Andreas Varkaris
, Yasutoshi Kuboki
, et al.
·
Journal of Clinical Oncology
·
4
Show more works
View as search
Works count:
1
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type
